Synergistic effect of polyoxotungstates in combination with β-lactam antibiotics on antibacterial activity against methicillin-resistant Staphylococcus aureus

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 3, 1996, Pages 459-465

  Yamase, Toshihiro ^a   Fukuda, Norio ^a   Tajima, Yutaka ^b  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

MRSA; penicillin binding protein 2'; polyoxotungstate; synergistic effect; lactam antibiotic

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFAZOLIN; MOLYBDIC ACID; OXACILLIN; PENICILLIN BINDING PROTEIN; PIPERACILLIN; POLYOXOTUNGSTATE DERIVATIVE; TUNGSTEN DERIVATIVE; UNCLASSIFIED DRUG; VANADIC ACID;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG POTENTIATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS;

EID: 0029965881     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.459     Document Type: Article

References (45)

1. Yamase T., Fujita H., Fukushima K., Inorg. Chim Acta, 151, 15-18 (1988).
2. a) Inouye Y., Take Y., Yoshida T., Yamamoto A., Yamase T , Nakamura S., Chem. Pharm. Bull., 38, 285-287 (1990);
3. b) Take Y , Tokutake Y., Inouye Y., Yoshida T., Yamamoto A., Yamase T., Nakamura S., Antiviral Research, 15, 113-124 (1991):
4. c) Fukuma M., Seto Y., Yamase T., ibid., 16, 327-339 (1991);
5. d) Ikeda S., Nishiya S , Yamamoto A., Yamase T., Nishimura C., De Clercq E., Antiviral Chem. Chemother , 5, 47-50 (1994);
6. e) Hill C. L., Weeks M. S., Schinazi R. F., J Med Chem., 33, 2767-2772 (1990).
7. a) Dormont D., Yeramian P., Lambert P., Spire B., Daveloose D , Barre-Sinoussi F., Chermann J. C. , Cancer Detect. Prev., 12, 181-194 (1988);
8. b) Rosenbaum W., Dormont D., Spire B., Vilmer E., Gentilini M., Griscelli C., Montagnier L., Barre-Smoussi F., Chermann J. C., Lancet, i. 450-451 (1985).
9. Moskovitz B. L. and the HPA-23 Cooperative Study Group, Antimicrob Agents Chemother., 32, 1300-1303 (1988).
10. Tajima Y, Nagasawa Z., Tadano J., Microbiol Immunol., 37, 695-703 (1993).
11. Jevons M. P., Br. Med. J., 1, 124-125 (1961).
12. Hallander H. O., Dornbusch K., Gezelius L., Jacobsen K., Karlsson I., Antimicrob. Agents Chemother., 22, 743-752 (1982).
13. a) Hartman B., Tomasz A., Antimicrob. Agents Chemother., 19, 726-735 (1981);
14. b) Ubukata K., Yamashita N., Konno M., ibid., 27, 851-857 (1985).
15. a) Hayes M. V., Cutis N. A. C., Wyke A. W., Ward J. B., FEMS Microbiol. Lett., 10, 119-122 (1981);
16. b) Hartman B., Tomasz A., J. Bacteriol., 158, 513-516 (1984).
17. Tajima Y., Nagasawa Z., Tanabe I., Kusaba K., Tadano J., Microbiol Immunol , 38, 639-648 (1994).
18. Matsumoto K. Y., Kobayashi A., Sasaki Y., Bull. Chem Soc Jpn , 48, 3146-3151 (1975).
19. Rocchiccioli-Deltcheff C., Fournier M., Franck R., Thouvenot R., Inorg. Chem., 22, 207-216 (1983).
20. Dommaille P. J., Knoth W. H., Inorg. Chem., 22, 818-822 (1983).
21. Smith D. P., So H., Bender J., Pope M. T., Inorg. Chem., 12, 685-688 (1973).
22. Dommaile P J., J Am. Chem. Soc., 106, 7677-7687 (1984).
23. Altenau J. J., Pope M. T.. Parados R. A., So H., Inorg Chem , 14. 417-421 (1975).
24. Dommaile P. J., Watunya G., Inorg. Chem., 25, 1239-1242 (1986).
25. Baker Louis C. W., Mccutcheon T. P., J Am. Chem. Soc., 78, 4503-4510 (1956).
26. Brevard C., Shimpf R., Tourné G., Tourné C., J. Am. Chem. Soc., 105, 7059-7063 (1983).
27. Massart R., Contant R., Fruchart T. M., Ciabrini J. P., Fournier M., Inorg. Chem., 16, 2916-2921 (1977).
28. Hervé G., Tézé A., Inorg. Chem., 16, 2115-2117 (1977).
29. Tourné C , Revel A., Tourne G., Vendrell M., C R. Acad. Sci., Ser. C., 277, 643-645 (1973).
30. Yamase T., Naruke H., Sasaki Y., J. Chem. Soc. Dalton Trans , 1990, 1687-1696.
31. Blasse G., Dirksen G. J., Zonnevijlle F., J. Inorg. Nucl. Chem , 43, 2847-2853 (1981).
32. Iball J., Low N. J., Weakley T. J. R., J. Chem. Soc. Dalton Trans., 1974, 2021-2024.
33. Naruke H., Yamase T , Acta Crystallogr., Sect. C, 48, 597-599 (1992).
34. Sergienko V. S., Molchanov V. N., Polai-Koshits M. A., Koord Khim., 5, 936-942 (1979).
35. Leyrie M., Hervé G., Nouv. J. Chim., 2, 233-237 (1978).
36. Michelon M., Hervé G., Leyrie M., J. Inorg. Nucl. Chem., 42, 1583-1586 (1980).
37. Filowitz M., Ho R. K. C., Klemperer W. G., Shum W., Inorg. Chem . 18, 93-103 (1979).
38. Gutierréz-Zorrilla J. M., Yamase T., Sugeta M., Acta Crystallogr., Sect. C, 50, 196-198 (1994).
39. Roman P., San. José A., Luque A.. Gutierréz-Zorrilla J. M., Inorg Chem., 32, 775-776 (1993).
40. Kobayashi A., Sasaki Y., Chem. Lett., 1975, 1123-1124.
41. Yamase T., Ohtaka K., J. Chem. Soc. Dalton Trans., 1994, 2599-2608.
42. Matsuhashi K. B., Faloona F., Meth. Enzymol., 155, 335-350 (1987).
43. National Committee for Clinical Laboratory Standards, "Performance standards for antimicrobial disk susceptibility tests, Approved Standard, NCCLS Document M2-A4." 4th ed. by National Committee for Clinical Laboratory Standards, Vol. 10, Villanova, PA, 1990.
44. Bradford M. M., Anal. Biochem., 72, 248-254 (1976).
45. Laemmli U. K., Nature (London), 227, 680-685 (1970).